US2006150267A1PendingUtilityA1

Methods of using testis-specific insulin homolog polypeptides

Assignee: ZYMOGENETICS INCPriority: Aug 2, 1996Filed: Mar 13, 2006Published: Jul 6, 2006
Est. expiryAug 2, 2016(expired)· nominal 20-yr term from priority
H04Q 11/0478C07K 14/62A61K 38/2221C07K 14/64
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides testis-specific insulin homolog polypeptides and polynucleotides encoding the polypeptides, as well as related compositions and methods are disclosed. The polypeptides and polynucleotides may be used within methods for enhancing viability of cryopreserved sperm, for enhancing sperm motility, to enhance fertilization in methods of assisted reproduction, as contraceptives and other related uses.

Claims

exact text as granted — not AI-modified
1 . A method of enhancing sperm motility wherein a Zins2 testis-specific insulin homolog polypeptide selected from the group consisting of: 
 (a) polypeptides comprising a sequence of amino acids encoded by the nucleotide sequence as shown in SEQ ID NO: 1 or SEQ ID NO:12;    (b) allelic variants of (a); and    (c) Zins2 testis-specific insulin homolog polypeptides which are at least 85% identical to (a) or (b);    is added to sperm, an egg, an egg-sperm mixture, prior to fertilization.    
     
     
         2 . A method of enhancing sperm motility according to  claim 1  wherein said Zins2 testis-specific insulin homolog is added to sperm following cryopreservation.

Join the waitlist — get patent alerts

Track US2006150267A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.